Canada markets close in 12 minutes

Curis, Inc. (CRIS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.07+0.02 (+0.13%)
As of 3:48PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close15.05
Open14.89
Bid15.11 x 1200
Ask15.16 x 1200
Day's Range14.75 - 15.33
52 Week Range0.76 - 17.40
Volume1,147,860
Avg. Volume2,949,483
Market Cap1.379B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.48
Earnings DateAug. 02, 2021 - Aug. 06, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est23.00
  • Why Curis Stock Crashed on Thursday
    Motley Fool

    Why Curis Stock Crashed on Thursday

    Following a serious pop for its stock on Wednesday, given very encouraging news about one of its pipeline drugs, Curis (NASDAQ: CRIS) saw its shares dive by almost 20% the following day. Curis released its first-quarter figures after market close on that otherwise glorious Wednesday.

  • Curis (CRIS) Q1 2021 Earnings Call Transcript
    Motley Fool

    Curis (CRIS) Q1 2021 Earnings Call Transcript

    Thank you and welcome to Curis first-quarter 2021 earnings call. Joining me on today's call are Jim Dentzer, president and chief executive officer; and Bob Martell, head of R&D. We will also be available for a question-and-answer period at the end of the call.

  • Curis Reports First Quarter 2021 Financial Results
    CoinDesk

    Curis Reports First Quarter 2021 Financial Results

    Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its financial results for the first quarter ended March 31, 2021.